Factor V Arg306 → Thr (factor V Cambridge) and factor V Arg306 → Gly mutations in venous thrombotic disease
Open Access
- 1 December 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 103 (3) , 888-890
- https://doi.org/10.1046/j.1365-2141.1998.01051.x
Abstract
We investigated the prevalence of two reported mutations of the factor V gene (factor V Arg306 → Thr, or factor V Cambridge, and factor V Arg306 → Gly) in 104 relatively young patients with verified venous thrombosis and in 208 age‐, sex‐ and race‐matched controls, in order to establish whether the two mutations are associated with increased predisposition for venous thrombosis. PCR amplification followed by BstNI and MspI digestion was employed to determine the genotypes, and each mutation was confirmed by DNA sequencing. Among the controls, one individual was found to be heterozygous for the factor V Arg306 → Thr mutation and one heterozygous for the factor V Arg306 → Gly mutation; none of the patients carried either mutation. Our findings do not support factor V Cambridge and factor V Arg306 → Gly as risk factors for venous thrombosis.Keywords
This publication has 10 references indexed in Scilit:
- A Novel Mutation of Arg306 of Factor V Gene in Hong Kong ChineseBlood, 1998
- Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein CBlood, 1998
- Thrombophilia as a Multigenic DisorderThrombosis and Haemostasis, 1997
- A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosisBlood, 1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977